FDA Adverse Event Death Summary report: N

LENIRE

MDR report key: 19072661 · Received April 9, 2024

Report

Report Number
3018030059-2024-00001
Event Type
Death
Date Received
April 9, 2024
Date of Event
February 23, 2024
Report Date
April 9, 2024
Manufacturer
NEUROMOD DEVICES LIMITED
Product Code
QVN
PMA / PMN Number
DEN210033
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GA, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

ADDITIONAL INFORMATION PROVIDED BY THE HEALTHCARE PROFESSIONAL: "1. EVENT DESCRIPTION: PATIENT TOOK HIS OWN LIFE ON (B)(6) 2024. 2. DATE OF INCIDENT: THE SPECIFIC DATE ON WHICH THE SUICIDE OCCURRED, TO THE EXTENT THAT THIS INFORMATION IS AVAILABLE. 3. DATE OF AWARENESS (HEALTHCARE PROFESSIONAL): (B)(6) 2024. 4. SOURCE OF REPORT: (B)(6) CALLED THE PATIENT FOR A SCHEDULED PROGRESS CHECK IN. HIS SPOUSE ANSWERED THE PHONE AND LET US KNOW THAT THE PATIENT HAD TAKEN HIS LIFE. 5. PATIENT INFORMATION: (B)(6), (B)(6) 1956, (B)(6). 6.DEVICE'S INVOLVEMENT: THERE WERE NO MALFUNCTIONS OR FAILURES OF THE DEVICE. THE ONLY INVOLVEMENT IS THAT THE PATIENT CAME TO US SEEKING LENIRE TINNITUS TREATMENT AND WAS FIT AND BEGAN TREATMENT WITH THE DEVICE. HE WAS SEEN FOR A COMPREHENSIVE TINNITUS EVALUATION AND FIT WITH LENIRE ON (B)(6) 2024. CHART NOTE FROM TELEPHONE CHECK IN ON (B)(6)2024: LENIRE 2 WEEK CHECK IN: PATIENT REPORTED THAT HE'S BEEN DOING HIS TREATMENTS TWICE A DAY - ONCE IN THE AM AND ONCE IN THE PM. HE REPORTED HE'S NOTICED A SPIKE IN THE TINNITUS AFTER THE MORNING SESSION, AND IT LASTS ABOUT 30 MINS. HE SAID THAT RECENTLY HE'S TURNED A CORNER IN SLEEP AND IT'S STARTING TO IMPROVE. PATIENT HAS VERY REALISTIC EXPECTATIONS AND WILL CONTINUE TREATMENT. RETURN TO CLNIC IN 1 MONTH FOR IN-PERSON VISIT".

Description of Event or Problem · 0

PATIENT TOOK HIS OWN LIFE ON (B)(6) 2024.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2288677 LENIRE LENIRE QVN NEUROMOD DEVICES LIMITED CR-201

Patients

Seq Age Sex Outcome Treatment
1 67 YR Male Death